2018 Speakers





World Vaccine Washington Congress

Dr Gregory A. Poland , Director of Mayo Vaccine Research Group, Mayo Clinic
Dr Justin Oritz , Affiliate Assistant Professor, Global Health, Affiliate Assistant Professor, Medicine Medical Officer, Initiative for Vaccine Research, World Health Organization
Dr Carl R. Alving , Emeritus Senior Scientist, Former Chief, Laboratory of Adjuvant & Antigen Research, U.S. Military HIV Research Program, Walter Reed Army Institute of Research
Dr Derek O'Hagan , Global Head of Discovery Support and New Technology, GSK Vaccines
Prof Mathuram Santosham , Johns Hopkins University, Professor, Departments of International Health and Pediatrics, Director Emeritus, Center for American Indian Health
Richard Hatchett , CEO, CEPI
Dr Peter Hotez , Dean of National School of Tropical Medicine, Baylor College of Medicine
Prof Stanley A. Plotkin , Emeritus Professor, University of Pennsylvania
Rahul Singhvi , COO, Takeda
Fred Moin Siyoi , Deputy Registrar, Pharmacy and Poisons Board, Nairobi, Kenya
Dr Rip Ballou , Head US R&D Center, GSK Vaccines
Dr Vasee Moorthy , Coordinator, Research, Ethics, Knowledge Uptake, Department of Information, Evidence and Research, & Team Leader, R&D Blueprint, WHO Geneva
Dr Michael Kalos , Chief Scientific Officer, Cancer Immunobiology, Eli Lilly
Dr Roy Baynes , Senior Vice President Global Clinical Development and Chief Medical Officer, MSD
Dr Bruce Gellin , President of Global Immunization, Sabin Institute
Dr Gary Nabel , Chief Scientific Officer & Senior Vice President Head, North America R&D Hub, Sanofi
Dr Angela Shen , ScD, MPH, CAPT, US Public Health Service, Senior Advisor, NVPO
Jeff Stoddard , Medical Affair Lead for Zoster Vaccines, GSK Vaccines
Prof Walter A. Orenstein , Professor and Associate Director; Influenza Pathogenesis & Immunology Research Center, Emory Vaccine Center
Dr Paul Offit , Director of the Vaccine Education Centre, The Children’s Hospital of Philadelphia
Dr Peter Kwong , Chief, Structural Biology Section, Vaccines Research Center, NIAID
Prof Felix Rey , Head of Structural Biology, Institut Pasteur
Dr Andrea Carfi , Senior Director, Antigen Design and Project Leader, Valera
Dr Sumana Chandramouli , Laboratory Head, Preclinical R&D, GSK Vaccines
Dr Hans Langedijk , Director Subunit Vaccine Design, Janssen Infectious Diseases and Vaccines
Dr Vu L. Truong , Founder, Chief Executive Officer, and Director, Aridus
Dr Steve Projan , Senior Vice President of Innovative Medicines, Research and Development and Head of Infectious  Diseases and Vaccines, Medimmune
Dr Eszter Nagy , Co-Founder, Chief Scientific Officer, and Managing Director, Arsanis Biosciences GmbH
Sushma Shivaswamy , Vice President, Research and Development, Xbiotech
Todd Black , Executive Director Infectious Diseases, Head Antibacterial and Antifungal Discovery, Merck
Surya Sankuratri , Executive Director, Business Development and Licensing, Merck
Ana Maria Henao-Restrepo , MD, Team Leader, Implementation Research, Initiative for Vaccine Research, Department of Immunization, Vaccines & Biological, WHO
Dr Ira Longini , Professor & Co-director, Center for Statistics and Quantitative Infectious Diseases (CSQUID) Emerging Pathogens Institute, University of Florida
Bruno Speder , Head Clinical Regulatory Affairs & Consultancy, SGS Life Sciences
Senior representative, PRA Health Sciences
Geoffrey Glauser , Senior Consultant Supply Chain, HHS/ASPR/BARDA
Senior representative, ClinicalRM
Dr Lisa Plitnick , Senior Principal Scientist, Pre-Clinical Vaccine Safety, Merck & Co .
More speakers TBC…



  Vaccine Emerging Diseases


Dr Scott Halstead , Adjunct Professor, Department of Preventive Medicine and Biometrics, Uniformed Services University of the Health Sciences

Dr Brad Gessner , Scientific Director, Association pour la Médicine Préventive (AMP)

Stephen J. Savarino , Associate Vice President, Translational Sciences and Dengue R&D Leader, Sanofi Pasteur*

Dr Steve Whitehead , Senior Associate Scientist, NIAID

Dr Duane J Gubler , Emeritus Professor, Programme in Emerging Infectious Diseases, Duke-NUS Medical School

Dr Uwe D. Staerz , MD, Chief Scientific Officer and Chairman, Board of Directors, Greffex

Dr Pei-Yong Shi , I.H. Kempner Professor of Human Genetics, utmb Health

Dr Erich Tauber , CEO and Founder, Themis Bioscience

Dr David L. Smith , Professor in the Department of Epidemiology, Johns Hopkins and the Center for Disease Dynamics, Economics & Policy, Washington, D.C

Dr Robert Reiner , Assistant Professor, Global Health, University of Washington

Dr Ira Longini , Professor & Co-director, Center for Statistics and Quantitative Infectious Diseases (CSQUID) Emerging Pathogens Institute, University of Florida

Dr Thomas W. Scott , Professor & Director, Mosquito Research Laboratory, Department of Entomology, University of California

Dr Mazen Hassanain , Founder, SaudiVax

Dr Maria Elena Bottazzi , Director of Product Development, Baylor College of Medicine

Prof Myron M. Levine, Grollman Distinguished Professor, Assoc. Dean for Global Health, Vaccinology & Infectious Diseases, University of Maryland School of Medicine

Dr Veronica Gambillara Fonck , Co-Founder & Chief Executive Officer, LimmaTech Biologics (GSK Vaccines)

Dr Peter Hotez , Dean of National School of Tropical Medicine, Baylor College of Medicine

Dr Wolfgang Bender , CMO, Valneva

More speakers TBC…


Bioprocessing and manufacturing


Dr Basav Ghosh , Senior Director, Manufacturing Sciences and Technology, Pfizer

Dr Bo Arve, Executive Director, BioPharmaceutical Sciences, Pfizer

Dr Hari Pujar , Vice President Technical Development and Manufacturing, Moderna Therapeutics

Dr Wendy Saffell-Clemmer , Director Research, Baxter BioPharma Solutions

Dr Darin Zehrung , Program Advisor and Portfolio Leader of the Vaccine and Pharmaceutical Delivery Technologies, PATH

Dr Michael Schjrader , Co-Founder and CEO, Vaxess Technologies Inc.

Dr Peter H. Khoury , CEO, Nanotherapeutics

Dr Don Gerson , CEO, PnuVax

Dr Yan-ping Yang , Head of Bioprocess Research & Development North America, Sanofi Pasteur

Glen Zimmermann , Sr. Director, Business Development,  Administration Systems, West Pharmaceutical Services*

Senior representative, GE Healthcare
Senior representative, Institute for Translational Vaccinology

Dr T. Max M Søgaard , Director of Process Development, Expres2ion Biotechnologies

Senior representative, Maxcyte

More speakers TBC…


Clinical Trials


Dr Marion Gruber , Director, Office of Vaccines Research and Review, CBER, FDA

Dr Arnaud Didierlaurent , Head Adjuvant Platform, GSK Vaccines 

Dr Darin Seehafer , Clinical Scientist/Program Director, PRA Health Sciences

Dr Steven Black , Professor of Pediatrics, Center for Global Health, University of Cincinnati Children’s Hospital in Ohio
Senior representative, Bioclinica Research Network

Dr Adrian Wildfire , Project Director - Infectious Diseases & Viral Challenge Unit, SGS Life Sciences

Dr Reserved for Cindy Dukes , VP, Global Project Management, ICON Clinical Research

Dr Wilhelm Muehlhausen , Head of Innovation, ICON Clinical Research

Thomas Lingelbach , President & CEO, Valneva

Dr Francisco Diaz-Mitoma , CMO, VBI Vaccines

Dr Chip Clarke , CEO, Genocea Biosciences

Dr Alan Cross , Clinical Professor, University of Maryland

Senior representative, Pfizer

Dr Annaliesa Anderson , VP Bacterial Vaccines, Pfizer

More speakers TBC…


Supply & Logistics


James Cheyne , Supply-chain consultant, Health service logistics

Laurie Werner , Better Immunization Data Initiative, PATH

Emily Bancroft , Acting President, Village Reach

Rebecca Coyle , Executive Director, American Immunization Registry Association (AIRA)

Julie Jacobson , Senior Program Officer, Infectious diseases, Bill & Melinda Gates Foundation

Jeff Rowland , Director Global Operational Partnerships, GAVI Alliance

Geoffrey Glauser , Senior Consultant Supply Chain, HHS/ASPR/BARDA

Senior Representative, Supply & Procurement, UNICEF*

Dr Matthew Burt , Vaccine Supply Chain Director, Pfizer

More speakers TBC…


Vaccine Partnerships


Dr Roman Chicz , Associate Vice President and Global Head of External Research and Development, Sanofi Pasteur

Dr Heinz Feldmann , Chief, Laboratory of Virology Chief, Disease Modeling and Transmission Section, NIAID, NIH

Dr Philippe Denoel , R&D, GSK Vaccines
Dr Sally Mossman , Head Preclinical R&D, GSK Vaccines US
David Hipkiss , Chief Executive Officer, Enesi Pharma Limited 
Dr BT Slingby , CEO, GHIT, Japan

Dr Stephen Nagler , Executive Director, MedPro Investors LLC

Dr Jerome Kim , Director General, IVI

Dr Jorge Kalil , Former Director of the Butantan Institute & Senior Profession or Immunology,  University of São Paulo’s Medical School and Heart Institute

Dr Steven Reed , Founder & CEO, Infectious Disease Research Institute (IDRI)

Dr Peter Dull , Deputy Director, Integrated Clinical Vaccine Development, Bill & Melinda Gates Foundation

Dr Nima Farzan , Chief Executive Officer, PaxVax

David Hipkiss , Chief Executive Officer, Enesi Pharma Limited

Prof James Moon , Department of Pharmaceutical Sciences and Biomedical Engineering, University of Michigan, Ann Arbor & CSO, EVOQ Therapeutics

Dr Dan Stinchcomb , CSO, IDRI

More speakers TBC…


Influenza and Respiratory


Dr Rino Rappuoli , Chief Vaccine Scientist, GSK Vaccines 

Dr Jerald Sadoff, Senior Advisor, Janssen Infectious Diseases and Vaccines

Dr Barney S. Graham , Senior Investigator, Viral Pathogenesis Laboratory, VRC, NIAID

Dr Martin Moore, Associate Professor , Interim Director of Research, Pediatric Infectious Diseases, Emory Children's Center & CEO/Co-Founder, Meissa Vaccines

Dr Philip R. Dormitzer , MD, Vice President and CSO: Viral Vaccines, Pfizer Vaccine Research and Development

Dr Giuseppe Ciaramella , CSO, Valera

Dr Kena Swanson , Research Lead, RSV, Pfizer

Beate Schmoele-Thoma,  Clinical Lead, RSV, Pfizer

Dr Gregory M. Glenn M.D ., President, Research and Development, Novavax*

Prof Emanuele Montomoli , Professor at the Public Health University of Siena & CSO, VisMederi

Dr Biol. Sci. Alessandro Sette , Center Head, Division Head, and Professor Center for Infectious Disease, L a Jolla Institute for Allergy and Immunology

Medical Officer, Medicago

Dr Sean Tucker , CSO, Vaxart Inc.

Senior representative, Viroclinics Biosciences 
Senior representative, Julius Clinical
Senior representative, Eurocine

Prof Louis Bont , Chairman of the board, ReSViNET

Dr Ilse Dieussaert , Head Maternal Immunization, GSK Vaccines

Dr Ann Ginsberg , Chief Medical Officer, Aeras

Dr Simona Rondini , Vaccine Development Lead, COPD Vaccine, GSK Vaccines

More speakers TBC…



Cancer & Immunotherapy


Dr Roy Baynes , SVP, and Head Global Clinical Development, Merck Research Laboratories

Dr Fred Ramsdell , Vice President, Research, Parker Institute for Cancer Immunotherapy (PICI)

Dr Douglas McNeel , Chief Medical Officer, Madison Vaccines Incorporated 

Dr Michael Kalos , Chief Scientific Officer, Cancer Immunobiology, Eli Lilly

Dr Corey Caspar , CSO, IDRI

Dr Robert Seder , Chief Cellular Immunology Section, Vaccine Research Center, NIAID, NIH

Dr Nina Bhardwaj , Director of Immunotherapy, Professor of Medicine, Division of Hematology & Oncology, Tisch Cancer Institute, Icahn School of Dr Medicine at Mount Sinai

Dr Erin Karski , Associated Medical Director, Genentech

Dr Michael Ciesielski , Assistant Professor of Neurosurgery, Department of Neurosurgery, Roswell Park Cancer Institute

Ildiko Csiki , ‎Vice President, Clinical Development Oncology, Inovio

Dr Jay Berzofsky , Chief, Vaccine Branch, Center for Cancer Research, National Cancer Institute

Nir Hacohen , Director, MGH Center for Cancer Immunotherapy, Broad Institute

More speakers TBC…




Dr Cyril Gay , Senior National Program Leader, Office of National Programs, USDA

Dr Mahesh Kumar,  Vice President, Global Biologics Research, Zoetis

Dr Klaus Osterrieder,  Managing Director, Institute of Virology, Free University of Berlin

Dr Robert Zolynas,  Vice President for Research and Development,  Bayer HealthCare

Dr Jeffery Ulmer , Head, Preclinical R&D, GSK Vaccines US

Dr Jens Gertow , Scientific Advisor, Mabtech
Alan Young, CSO, Medgene Labs 

Professor Thomas W Geisbert , Microbiology & Immunology, The University of Texas Medical Branch at Galveston

Dr Federico Zuckermann , Chief Scientific Officer, Aptimmune

Dr Kemal Karaca , Director Product Development, Elanco

Dr Stéphane Lemiere,  Technical Director (Avian), Merial

Dr Stacy Sneeringer , Research Economist at Economic Research Service, USDA

Rhonda LaFleur , Project Leader, Principal Scientist, R&D Department, Merck Animal Health

Alex Morrow , Chair, STAR-IDAZ IRC

More Speakers TBC


Vaccine Safety


Dr Peter Hotez, President of the Sabin Institute & Dean of National School of Tropical Medicine Sabin Institute, Baylor College of Medicine

Dr Paul Offit, Chief of the Division of Infectious Diseases and the Director of the Vaccine Education Center, Children’s Hospital of Philadelphia; Perelman School of Medicine at UPenn

Dr Heidi Larson , Director; PROFESSOR OF ANTHROPOLOGY, RISK AND DECISION SCIENCE, The Vaccine Confidence Project,  London School of Hygiene and Tropical Medicine

Dr Saad Omer, Professor Global Health, Epidemiology and Pediatrics, Emory Vaccine Center, Emory University, Schools of Public Health & Medicine

Jens-Ulrich Stegmann , VP Head Clinical Safety & Pharmacovigilance, GSK

Dr Neal Halsey , Professor, International Health, Global Disease Epidemiology and Control,  Johns Hopkins Bloomberg School of Public Health

Dr Prof Dan Salmon , Global Disease Epidemiology and Control; Deputy Director JHU’s Institute for Vaccine Safety,  Johns Hopkins Bloomberg School of Public Health

Dr Dorit Rubinstein Reiss , Professor of Law, UC Hastings

Dr Marta Tomasi , Post-doc researcher, Free University of Bozen-Bolzano

Dr Margie  Danchin , Senior Research Fellow, Vaccine and Immunization Research Group, Murdoch Children's Research Institute

Dr Jason Schwartz , Assistant Professor of Public Health Policy, Yale School of Public Health

Dr Walter  Straus , Associate Vice President, Therapeutic Area Head, Clinical Safety & Risk Management, Merck & Co.

Dr Karen Broder , Medical Officer, Immunization Safety Office, CDC

Dr Hector Izurieta , Epidemiologist, Immediate Office of the Director. Office of Biostatistics and Epidemiology, CBER/FDA, Food and Drug Administration * TBC

Dr Karin Bok , Senior Vaccine Science Advisor, National Vaccine Program Office, Office of the Assistant Secretary for Health, HHS

Dr Ashley Wivel , Senior Principal Scientist, Clinical Safety and Risk Management, Global Safety Physician for Ebola Vaccine Program, Merck & Co.

More speakers TBC…


Immune Profiling


Dr Wayne C. Koff , President and CEO, The Human Vaccines Project

Dr Alison Deckhut Augustine , Chief, Basic Immunology Branch, NIAID/NIH

Dr Robert A. Seder , Chief, Cellular Immunology Section, Vaccine Research Center, NIAID/ NIH

Dr Drew Pardoll , Director, Bloomberg Kimmel Institute for Cancer Immunotherapy

Dr Robert Schreiber , Distinguished Professor, Pathology and Immunology; Director, Bursky Center for Human Immunology and Immunotherapy Programs, Washington University

Professor of Oncology, Johns Hopkins University

Dr Margo Roberts , CSO, Kite Pharma

Hyam Levitsky , CSO, Juno Therapeutics

Giuseppe Del Giudice , Translational Science Leader, GSK

Dr James Crowe , Director, Vanderbilt Vaccine Center Immunologist, NIH Board-Certified Pediatric Infectious Diseases Specialist, Professor, Pediatrics and Pathology, Microbiology and Immunology, Vanderbilt Vaccine Center

Dr Steven Townson , Oncology Scientific Director, Principal Scientist, Clinical Research Oncology Early Development, Merck & Co Inc

Dr Jennifer Brogdon , Director, Exploratory Immuno-Oncology, Novartis

Dr Samik Basu , Director, Translational Science, Adaptimmune

Dr Ezio Bonvini , Senior Vice President, Research & Chief Scientific Officer, Macrogenics

More speakers TBC…